SCWorx Reports Nasdaq Delisting and Material Control Weaknesses, Despite Narrowed Q1 Net Loss
summarizeSummary
SCWorx Corp. faces severe challenges with its Nasdaq delisting and material internal control weaknesses, despite reporting a reduced net loss and improved gross profit for the first quarter.
check_boxKey Events
-
Nasdaq Delisting Confirmed
The company received a delisting notice from Nasdaq on April 7, 2026, for failing to meet the minimum bid price. Trading was suspended on April 14, 2026, though an appeal has been filed.
-
Material Weaknesses in Internal Controls
Management concluded that disclosure controls were not effective as of March 31, 2026, due to deficiencies in design and lack of segregation of duties.
-
Narrowed Net Loss in Q1 2026
Net loss significantly decreased to $173,767 for the three months ended March 31, 2026, compared to a net loss of $476,303 for the same period in 2025.
-
Improved Gross Profit
Gross profit increased to $374,109 in Q1 2026 from $136,863 in Q1 2025, driven by reduced labor and cloud hosting costs.
auto_awesomeAnalysis
SCWorx Corp. has been delisted from the Nasdaq Capital Market, with trading suspended on April 14, 2026, due to its failure to meet the minimum bid price requirement. The company has filed an appeal, but the delisting is a severe blow to its public market access. Compounding this, management identified material weaknesses in internal controls over financial reporting as of March 31, 2026, citing design deficiencies and lack of segregation of duties. While the company reported a significantly narrowed net loss of $173,767 for Q1 2026 (compared to $476,303 in Q1 2025) and increased gross profit, these operational improvements are overshadowed by the critical governance and compliance issues. The company continues to burn cash from operations, with cash decreasing to $1.34 million, indicating a short runway without further capital raises.
At the time of this filing, WORX was trading at $0.36 on OTC in the Technology sector, with a market capitalization of approximately $382.5K. The 52-week trading range was $0.33 to $12.01. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.